15-deoxy-Δ12,14-prostaglandin J2:: The endogenous electrophile that induces neuronal apoptosis

被引:154
作者
Kondo, M
Shibata, T
Kumagai, T
Osawa, T
Shibata, N
Kobayashi, M
Sasaki, S
Iwata, M
Noguchi, N
Uchida, K [1 ]
机构
[1] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan
[2] Tokyo Womens Med Univ, Dept Pathol, Tokyo, Japan
[3] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan
[4] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Genome Sci, Tokyo 1538904, Japan
关键词
D O I
10.1073/pnas.112212599
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostaglandin D-2 (PGD(2)), a major cyclooxygenase product in a variety of tissues and cells, readily undergoes dehydration to yield the bioactive cyclopentenone-type PGs of the J(2)-series, such as 15-deoxy-Delta(12,14)-PGJ(2) (15d-PGJ(2)). The observation that the level of 15d-PGJ(2) increased in the tissue cells from patients with sporadic amyotrophic lateral sclerosis suggested that the formation of 15d-PGJ(2) may be closely associated with neuronal cell death during chronic inflammatory processes. In vitro experiments using SH-SY5Y human neuroblastoma cells revealed that 15d-PGJ(2) induced apoptotic cell death. An oligonucleotide microarray analysis demonstrated that, in addition to the heat shock-responsive and redox-responsive genes, the p53-responsive genes, such as gadd45, cyclin G1, and cathepsin D, were significantly up-regulated in the cells treated with 15d-PGJ(2). Indeed, the 15d-PGJ(2) induced accumulation and phosphorylation of p53, which was accompanied by a preferential redistribution of the p53 protein in the nuclei of the cells and by a time-dependent increase in p53 DNA binding activity, suggesting that p53 accumulated in response to the treatment with 15d-PGJ(2) was functional. The 15d-PGJ(2)-induced accumulation of p53 resulted in the activation of a death-inducing caspase cascade mediated by Fas and the Fas ligand.
引用
收藏
页码:7367 / 7372
页数:6
相关论文
共 35 条
  • [1] Brown JM, 1999, CANCER RES, V59, P1391
  • [2] BUNZ F, 1976, J BIOL CHEM, V251, P6550
  • [3] Early de novo gene expression is required for 15-deoxy-Δ12,14-prostaglandin J2-induced apoptosis in breast cancer cells
    Clay, CE
    Atsumi, G
    High, KP
    Chilton, FH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 47131 - 47135
  • [4] MITOCHONDRIAL MODIFICATIONS DURING RAT THYMOCYTE APOPTOSIS - A STUDY AT THE SINGLE-CELL LEVEL
    COSSARIZZA, A
    KALASHNIKOVA, G
    GRASSILLI, E
    CHIAPPELLI, F
    SALVIOLI, S
    CAPRI, M
    BARBIERI, D
    TROIANO, L
    MONTI, D
    FRANCESCHI, C
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 214 (01) : 323 - 330
  • [5] de la Monte SM, 1998, LAB INVEST, V78, P401
  • [6] APOPTOSIS IN CANCER-THERAPY - CROSSING THE THRESHOLD
    FISHER, DE
    [J]. CELL, 1994, 78 (04) : 539 - 542
  • [7] FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713
  • [8] BIOLOGICAL-ACTIVITIES AND MECHANISMS OF ACTION OF PGJ2 AND RELATED-COMPOUNDS - AN UPDATE
    FUKUSHIMA, M
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1992, 47 (01): : 1 - 12
  • [9] P53 and the CNS - Tumors and developmental abnormalities
    Fulci, G
    Van Meir, EG
    [J]. MOLECULAR NEUROBIOLOGY, 1999, 19 (01) : 61 - 77
  • [10] THE BIOLOGY AND PHARMACOLOGY OF PGD2
    GILES, H
    LEFF, P
    [J]. PROSTAGLANDINS, 1988, 35 (02): : 277 - 300